USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Avi Biopharma, Inc.
City: Corvallis
State: OR
Zip+4: 97333 0106
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (541) 753-3635

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $920,111.00 5
STTR Phase I $262,849.00 3
STTR Phase II $424,266.00 1

Award List:

THERAPEUTIC APPLICATIONS OF PERFLUOROCARBON MICROBUBBLES

Award Year / Program / Phase: 1998 / STTR / Phase I
Agency: HHS
Research Institution: University of Nebraska
Principal Investigator: Iversen
Award Amount: $98,771.00
RI Contact: N/A

N/A

Award Year / Program / Phase: 2000 / STTR / Phase I
Agency: HHS
Research Institution: University of Nebraska
Principal Investigator: Iversen
Award Amount: $0.00
RI Contact: N/A

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Patrick L. Iversen
Award Amount: $98,415.00

Inhibition of Androgen Receptor to treat Prostate Cancer

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Gayathri R. Devi
Award Amount: $250,000.00
Abstract:
DESCRIPTION (provided by applicant): Prostate cancer is the second leading cause of cancer death in US men. Prostate cancer is highly dependent on androgen stimulation mediated through the androgen receptor (AR) for growth and proliferation. For those with advanced PCa, androgen ablation remains… More

Antisense Morpholino Oligomers to Treat Retinopathy

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Gayathri R. Devi
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): The broad, long-term objectives of the application are to develop antisense inhibitors of retinopathy and document their mechanism(s) of action. Retinopathy is a significant cause of eye disease and has a major impact on development, learning, communicating,… More

Morpholino Antisense Drugs for Hepatitis C Virus

Award Year / Program / Phase: 2004 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Principal Investigator: Cornelis A. Rijnbrand
Award Amount: $164,078.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Hepatitis C Virus (HCV) causes a persistent infection in most humans exposed to the virus. HCV infection in time can lead to cirrhosis and hepatocellular carcinoma. Although the annual number of newly infected patients has dropped significantly over the past… More

Apoptotic Regulation of Lymphocyte Responses

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Dan V. Mourich
Award Amount: $107,000.00
Abstract:
DESCRIPTION (provided by applicant): The response of lymphocytes to antigen stimulation is characterized by proliferation of an antigen-sensitive lymphocyte population, subsequent differentiation to subsets with effector cell function, and ultimately the retention of antigen-responsive lymphocytes… More

Antisense Antiviral Agent for West Nile Infections

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Patrick L. Iversen
Award Amount: $364,696.00
Abstract:
DESCRIPTION (provided by applicant): AVI BioPharma has been developing an antisense phosphorodiamidate morpholino oligomer, AVI-4020 for the treatment of West Nile Virus. AVI-4020 has been shown both to reduce viral titer, and to cross the blood brain barrier. This compound targets the translation… More